Skip to Content

C NVR (Zortress 0.25 mg)

Generic Name: everolimus

This pill with imprint "C NVR" is White, Round and has been identified as Zortress 0.25 mg. It is manufactured by Novartis Pharmaceuticals.

Zortress is used in the treatment of neuroendocrine carcinoma; organ transplant, rejection prophylaxis; brain tumor and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Zortress 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zortress
Generic Name:
everolimus
Imprint:
C NVR
Strength:
0.25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0417
Inactive Ingredients:
butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide